{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T12:18:08Z","timestamp":1790511488580,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AG027443"],"award-info":[{"award-number":["AG027443"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AG006173"],"award-info":[{"award-number":["AG006173"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.nbd.2015.05.020","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T21:03:40Z","timestamp":1433624620000},"page":"152-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Systematic analysis of time-dependent neural effects of soluble amyloid \u03b2 oligomers in culture and in vivo: Prevention by scyllo-inositol"],"prefix":"10.1016","volume":"82","author":[{"given":"Ming","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis J.","family":"Selkoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.05.020_bb0005","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1073\/pnas.90.2.567","article-title":"Alzheimer disease amyloid \u03b2 protein forms calcium channels in bilayer membranes: blockade by trimethamine and aluminum","volume":"90","author":"Arispe","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.05.020_bb0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2015.05.020_bb0015","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1523\/JNEUROSCI.23-26-08844.2003","article-title":"In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-beta metabolism and half-life","volume":"23","author":"Cirrito","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.05.020_bb0020","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/ana.23748","article-title":"Amyloid-beta oligomerization in Alzheimer dementia versus high-pathology controls","volume":"73","author":"Esparza","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.05.020_bb0025","doi-asserted-by":"crossref","first-page":"20033","DOI":"10.1073\/pnas.0910338106","article-title":"Stabilization of Ca2+-permeable AMPA receptors at perisynaptic sites by GluR1\u2013S845 phosphorylation","volume":"106","author":"He","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.05.020_bb0030","doi-asserted-by":"crossref","first-page":"16755","DOI":"10.1523\/JNEUROSCI.4521-10.2010","article-title":"Reimagining Alzheimer's disease \u2014 an age-based hypothesis","volume":"30","author":"Herrup","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.05.020_bb0035","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1073\/pnas.1017033108","article-title":"Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration","volume":"108","author":"Jin","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2015.05.020_bb0040","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/00005072-198711000-00001","article-title":"Tau epitopes are incorporated into a range of lesions in Alzheimer's disease","volume":"46","author":"Joachim","year":"1987","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2015.05.020_bb0045","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1523\/JNEUROSCI.3501-06.2007","article-title":"Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease","volume":"27","author":"Lacor","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.05.020_bb0050","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","article-title":"Soluble oligomers of amyloid beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake","volume":"62","author":"Li","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.05.020_bb0055","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0203-11.2011","article-title":"Soluble Abeta oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors","volume":"31","author":"Li","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.05.020_bb0060","doi-asserted-by":"crossref","first-page":"a006247","DOI":"10.1101\/cshperspect.a006247","article-title":"Biochemistry and cell biology of tau protein in neurofibrillary degeneration","volume":"2","author":"Mandelkow","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.nbd.2015.05.020_bb0065","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/jmbi.1998.1677","article-title":"Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest","volume":"278","author":"McLaurin","year":"1998","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.nbd.2015.05.020_bb0070","doi-asserted-by":"crossref","first-page":"18495","DOI":"10.1074\/jbc.M906994199","article-title":"Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit Abeta-induced toxicity","volume":"275","author":"McLaurin","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2015.05.020_bb0075","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm1423","article-title":"Cyclohexanehexol inhibitors of Abeta aggregation prevent and reverse Alzheimer phenotype in a mouse model","volume":"12","author":"McLaurin","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2015.05.020_bb0080","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1042\/BJ20140219","article-title":"Abeta dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies","volume":"461","author":"O'Malley","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2015.05.020_bb0085","doi-asserted-by":"crossref","first-page":"14946","DOI":"10.1523\/JNEUROSCI.4305-10.2010","article-title":"Amyloid-independent mechanisms in Alzheimer's disease pathogenesis","volume":"30","author":"Pimplikar","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2015.05.020_bb0090","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.neurobiolaging.2010.05.022","article-title":"Mechanisms of AD neurodegeneration may be independent of Abeta and its derivatives","volume":"32","author":"Robakis","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2015.05.020_bb0095","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0896-6273(00)80144-0","article-title":"Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit","volume":"16","author":"Roche","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.05.020_bb0100","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.0b013e3182309fa5","article-title":"A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease","volume":"77","author":"Salloway","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.05.020_bb0105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2015.05.020_bb0110","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.neuron.2008.11.007","article-title":"Linking Abeta and tau in late-onset Alzheimer's disease: a dual pathway hypothesis","volume":"60","author":"Small","year":"2008","journal-title":"Neuron"},{"issue":"Pt 1","key":"10.1016\/j.nbd.2015.05.020_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/bj2960015","article-title":"Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling","volume":"296","author":"Sutherland","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.nbd.2015.05.020_bb0120","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ana.21051","article-title":"Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers","volume":"60","author":"Townsend","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2015.05.020_bb0125","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/416535a","article-title":"Naturally secreted oligomers of the Alzheimer amyloid? Protein potently inhibit hippocampal long-term potentiation in vivo","volume":"416","author":"Walsh","year":"2002","journal-title":"Nature"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115001953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115001953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T19:48:50Z","timestamp":1540583330000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115001953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":25,"alternative-id":["S0969996115001953"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.05.020","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic analysis of time-dependent neural effects of soluble amyloid \u03b2 oligomers in culture and in vivo: Prevention by scyllo-inositol","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}